Ireland· IE-PA-PA25506/006/003

Rhinolast S nasal spray, solution

A azelastine product containing azelastine hydrochloride, registered in Ireland by Cooper Consumer Health B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC R01AC03

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about azelastine hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Azelastine is registered in 11 of 19 countries.

Countries holding a registration under ATC R01AC03 (azelastine), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
7 of them publish a price we can compare per daily dose

Search azelastine products by name

Azelastine · ATC R01AC03

11 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Netherlands
Polandprice
Switzerlandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)

Active substance: Azelastine hydrochloride
Manufacturer: Cooper Consumer Health B.V.
Country: Ireland (IE)
ATC code: R01AC03
ATC class: Azelastine
Defined daily dose: 0.56 mg, N
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
PA25506/006/003

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

201 interactions on record for azelastine.

Graded by severity as the source publishes them — 200 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check azelastine against other medicines How interaction checks work

Azelastine · interactions on record

201 records

200 moderate
1 minor

Most severe, free to view

MetoclopramideA03FA01moderate
DiphenhydraminA04AB05moderate
TriflupromazinA04AD06moderate
NabiloneA04AD11moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Azelastine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All azelastine products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Allergodil, Allergospray
Belgium · Allergodil, Azelergo
Bulgaria · Алергодил, Анталерг
Czechia · Allergodil, Allergodil Forte
Germany · Allergo-Azelind, Allergodil
Denmark · Allergodil, Allergodil Forte
Estonia · Allergodil
Spain · Afluon, Afluón
Finland · Lastin
France · Allergodil, Alonest
United Kingdom (Northern Ireland) · Astepro, Azelair
Greece · Afluon
Croatia · Vivialle, Vivispray
Hungary · Allergodil, Allergodil Forte
Iceland · Astepro, Lastin
Italy · Allergodil, Allespray
Lithuania · Allergodil
Luxembourg · Allergodil, Azelergo
Latvia · Allergodil
Malta · Antalerg Unimed Pharma, Azelastin-Comod
Netherlands · Allergodil, Allergodil Nevel
Norway · Lastin
Poland · Acatar Allergy, Allergodil
Portugal · Allergodil, Astepro
Romania · Allegodil, Allergodil
Sweden · Azelastine Omnivision
Slovenia · Alezaxin, Allergodil
Slovakia · Allergodil, Antalerg

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d3b435a6-a2f3-4293-a0c3-af7027b80738
GET /v1/drugs/d3b435a6-a2f3-4293-a0c3-af7027b80738?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Nasal spray, solution",
  "routes": [
    "Nasal use"
  ],
  "source": "hpra",
  "atc_all": [
    "R01AC",
    "R01AC03"
  ],
  "strength": null,
  "pa_number": "PA25506/006/003",
  "substances": [
    "Azelastine hydrochloride"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "13/09/2013",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about azelastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console